about
CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferationThe transcription factor PLZF directs the effector program of the NKT cell lineageMAIT cells detect and efficiently lyse bacterially-infected epithelial cellsStepwise development of MAIT cells in mouse and humanAntimicrobial activity of mucosal-associated invariant T cells.Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation.MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution.Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAPWhole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation.Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.Mucosal-associated invariant T cells: unconventional development and function.SYK expression endows human ZAP70-deficient CD8 T cells with residual TCR signaling.Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility.Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells.A novel hypomorphic mutation in STIM1 results in a late-onset immunodeficiency.Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency.Erratum: Corrigendum: Antimicrobial activity of mucosal-associated invariant T cellsSublingual vaccines based on wild-type recombinant allergensCTP synthetase activity assay by liquid chromatography tandem mass spectrometry in the multiple reaction monitoring modeConcomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells
P50
Q24298423-A69A098A-4825-4240-8E52-CC70936565F4Q24654999-C5710BFE-B226-4B49-9FBD-6C91014A5613Q27332162-84DF504A-B0F1-4B2E-9AA1-4C6620666180Q33417043-B82BA65E-C335-40A9-A700-CEBDC167A25BQ34022899-A25BA19E-ABF5-4741-8855-39D06B61AC95Q35829274-26EBDD48-2C6C-4B6E-915E-8335505F9404Q37208551-CA432199-5BC3-4AB8-ABCF-0AEFA2C41018Q37298583-F09387F6-7C2D-4746-85DF-AAFB658D9221Q37298590-A27EB1E2-41A4-4577-AAF2-7F1388C1813AQ37549726-846AC710-A69A-456A-99DC-1667131A8456Q37860732-8740F444-EA1C-4F9A-8A6F-67DD3A227F72Q41102427-84EA0A2F-D467-4507-8BF0-BC4E4F2BC6DDQ47560126-40CD9863-3D93-48A7-B69F-D45A26E416BBQ51030308-45214DCB-24BB-4C81-93B8-1652C9673CCBQ53521447-83020828-76DB-4AD1-A7BA-E33E22878553Q54483064-3ED6D85B-B8C4-43FC-BB43-A7A3E7963636Q57225176-64535F4F-9258-4850-956F-D0D56C65E21EQ79380458-5CC9FFB6-71BD-4A24-97F9-DE154F7DC169Q90119901-E24C1EFA-3D60-41EF-BB9F-E67BC9A02E6EQ90182344-04DD7D92-500C-4C4F-94C4-F05587E352C6
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Emmanuel Martin
@ast
Emmanuel Martin
@en
Emmanuel Martin
@es
Emmanuel Martin
@nl
Emmanuel Martin
@sl
type
label
Emmanuel Martin
@ast
Emmanuel Martin
@en
Emmanuel Martin
@es
Emmanuel Martin
@nl
Emmanuel Martin
@sl
prefLabel
Emmanuel Martin
@ast
Emmanuel Martin
@en
Emmanuel Martin
@es
Emmanuel Martin
@nl
Emmanuel Martin
@sl
P108
P106
P108
P31
P496
0000-0003-4211-7373